Approval · Notice of Compliance 9192 · 2007
GEN-BICALUTAMIDE: Notice of Compliance 9192
Issued November 23, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9192
- Date
- November 23, 2007
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Non-steroidal antiandrogen
- Canadian reference product
- CASODEX (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-BICALUTAMIDE | 02302403 | Cancelled Post Market |
Medicinal ingredients
- BICALUTAMIDE 50 MG per TAB